259 related articles for article (PubMed ID: 33371476)
21. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus Replication by Interfering with Viral Attachment Processes.
Fikatas A; Vervaeke P; Martínez-Gualda B; Martí-Marí O; Noppen S; Meyen E; Camarasa MJ; San-Félix A; Pannecouque C; Schols D
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31932383
[TBL] [Abstract][Full Text] [Related]
24. Progress in the identification of dengue virus entry/fusion inhibitors.
De La Guardia C; Lleonart R
Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
[TBL] [Abstract][Full Text] [Related]
25. Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides.
Cifuentes Kottkamp A; De Jesus E; Grande R; Brown JA; Jacobs AR; Lim JK; Stapleford KA
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894466
[TBL] [Abstract][Full Text] [Related]
26. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
27. A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-dengue and anti-Zika virus activity.
Ruan J; Rothan HA; Zhong Y; Yan W; Henderson MJ; Chen F; Fang S
Sci Rep; 2019 Jul; 9(1):10901. PubMed ID: 31358863
[TBL] [Abstract][Full Text] [Related]
28. Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.
Jiménez de Oya N; Esler WP; Huard K; El-Kattan AF; Karamanlidis G; Blázquez AB; Ramos-Ibeas P; Escribano-Romero E; Louloudes-Lázaro A; Casas J; Sobrino F; Hoehn K; James DE; Gutiérrez-Adán A; Saiz JC; Martín-Acebes MA
Emerg Microbes Infect; 2019; 8(1):624-636. PubMed ID: 30999821
[TBL] [Abstract][Full Text] [Related]
29. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M
ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
31. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
Majerová T; Novotný P; Krýsová E; Konvalinka J
Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
[TBL] [Abstract][Full Text] [Related]
32. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR
mBio; 2017 May; 8(3):. PubMed ID: 28465426
[TBL] [Abstract][Full Text] [Related]
33. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein.
Sharma N; Prosser O; Kumar P; Tuplin A; Giri R
Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901
[TBL] [Abstract][Full Text] [Related]
34. Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.
Wang X; Xia S; Zou P; Lu L
Viruses; 2019 Nov; 11(11):. PubMed ID: 31731598
[TBL] [Abstract][Full Text] [Related]
35. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
36. Halogenated Chrysins Inhibit Dengue and Zika Virus Infectivity.
Suroengrit A; Yuttithamnon W; Srivarangkul P; Pankaew S; Kingkaew K; Chavasiri W; Boonyasuppayakorn S
Sci Rep; 2017 Oct; 7(1):13696. PubMed ID: 29057920
[TBL] [Abstract][Full Text] [Related]
37. An Antiviral Peptide from
Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
[TBL] [Abstract][Full Text] [Related]
38. Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.
Kim SY; Koetzner CA; Payne AF; Nierode GJ; Yu Y; Wang R; Barr E; Dordick JS; Kramer LD; Zhang F; Linhardt RJ
Biochemistry; 2019 Feb; 58(8):1155-1166. PubMed ID: 30698412
[TBL] [Abstract][Full Text] [Related]
39. Baicalein and baicalin as Zika virus inhibitors.
Oo A; Teoh BT; Sam SS; Bakar SA; Zandi K
Arch Virol; 2019 Feb; 164(2):585-593. PubMed ID: 30392049
[TBL] [Abstract][Full Text] [Related]
40. The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant
Haddad JG; Grauzdytė D; Koishi AC; Viranaicken W; Venskutonis PR; Nunes Duarte Dos Santos C; Desprès P; Diotel N; El Kalamouni C
Molecules; 2020 May; 25(10):. PubMed ID: 32429073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
